Rapid and Slow Progressors Show Increased IL-6 and IL-10 Levels in the Pre-AIDS Stage of HIV Infection

PLoS One. 2016 May 23;11(5):e0156163. doi: 10.1371/journal.pone.0156163. eCollection 2016.

Abstract

Cytokines are intrinsically related to disease progression in HIV infection. We evaluated the plasma levels of Th1/Th2/Th17 cytokines in extreme progressors, including slow (SPs) and rapid (RPs) progressors, who were thus classified based on clinical and laboratory follow-up covering a period of time before the initiation of HAART, ranging from 93-136.5 months for SPs and 7.5-16.5 months for RPs. Analyses were also performed based on the different stages of HIV infection (chronic, pre-HAART individuals-subjects sampled before initiating HAART but who initiated therapy from 12 to 24 months-and those receiving HAART). The plasma cytokine levels of 16 HIV-infected rapid progressors and 25 slow progressors were measured using a Human Th1/Th2/Th17 CBA kit. The IL-6 and IL-10 plasma levels differed significantly between the stages of HIV infection. The IL-6 levels were higher in slow progressors pre-HAART than in chronically infected SPs and HIV-seronegative individuals. The IL-10 levels were higher in slow progressors pre-HAART than in slow progressors receiving HAART and HIV-seronegative controls, and in rapid progressors, the IL-10 levels were higher in pre-HAART subjects than in HIV-seronegative controls. The results reflect the changes in the cytokine profile occurring during different clinical stages in HIV+ subjects. Our results suggest an association between increased IL-6 and IL-10 levels and pre-HAART stages independent of the slow or rapid progression status of the subjects. Thus, increased IL-6 and IL-10 levels could indicate a global inflammatory status and could be used as markers of the disease course in HIV-infected individuals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / blood*
  • Adult
  • Disease Progression
  • Female
  • Follow-Up Studies
  • HIV Infections / blood*
  • HIV Infections / pathology
  • HIV-1
  • Humans
  • Interleukin-10 / blood*
  • Interleukin-6 / blood*
  • Male
  • Middle Aged
  • Prodromal Symptoms*
  • Retrospective Studies
  • Time Factors

Substances

  • IL10 protein, human
  • Interleukin-6
  • Interleukin-10

Grants and funding

This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) [grant numbers 190760/2010-9 and 306349/2011-6]; Fundação de Amparo à Pesquisa do Rio Grande do Sul (FAPERGS) [Grant number 12/2151-2].